In vivo enhancement of anticancer therapy using bare or chemotherapeutic drug-bearing nanodiamond particles

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 1065-1082

  Li, Yingqi ^a,b   Tong, Yaoli ^a   Cao, Ruixia ^a   Tian, Zhimei ^b   Yang, Binsheng ^b   Yang, Pin ^b  

^a Key Laboratory for Chemical Biology of Fujian Province   (China)

^b SHANXI UNIVERSITY   (China)

Author keywords

Cancer; Drug delivery; Nanodiamond; Survival rate; Sustained release; Treatment

Indexed keywords

DOXORUBICIN; NANODIAMOND; ANTINEOPLASTIC AGENT; DELAYED RELEASE FORMULATION; DRUG CARRIER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CELL STRAIN HEPG2; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIALYSIS; DRUG ADSORPTION; DRUG EFFICACY; DRUG SAFETY; DRUG UPTAKE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; LASER MICROSCOPY; LIVER CANCER; LIVER TOXICITY; MALE; MOUSE; NANOPHARMACEUTICS; NEPHROTOXICITY; NONHUMAN; SURVIVAL RATE; SURVIVAL TIME; SUSTAINED DRUG RELEASE; TOXICITY TESTING; ANIMAL; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG SCREENING; HEPG2 CELL LINE; LIVER NEOPLASMS, EXPERIMENTAL; METABOLISM; NANOMEDICINE; PATHOLOGY; PH; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HEP G2 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LIVER NEOPLASMS, EXPERIMENTAL; MICE; NANODIAMONDS; NANOMEDICINE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896856405     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S54864     Document Type: Article

References (46)

1. Nakamura E, Isobe H. Functionalized fullerenes in water. Acc Chem Res. 2003;36:807-815.
2. Lin Y, Taylor S, Li H, et al. Advances toward bioapplications of carbon nanotubes. J Mater Chem. 2004;14:527-541.
3. Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun. 2005;5:571-577.
4. Chen X, Tam UC, Czlapinski JL, et al. Interfacing carbon nanotubes with living cells. J Am Chem Soc. 2006;128:6292-6293.
5. Manna SK, Sarkar S, Barr J, et al. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-KB in human keratinocytes. Nano Lett. 2005;5:1676-1684.
6. Lacerda L, Bianco A, Prato M, Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv Drug Deliv Rev. 2006;58:1460-1470.
7. Schrand AM, Huang HJ, Carlson CJ, Schlager J, Osawa ES, Hussain ML. Are diamond nanoparticles cytotoxic? J Phys Chem B. 2007;111:2-7.
8. Yu SJ, Kang MW, Chang HC, Chen KM, Yu YC. Bright fuorescent nanodiamonds: no photobleaching and low cytotoxicity. J Am Chem Soc. 2005;127:17604-17605.
9. Wang DX, Tong YL, Li YQ, Tian ZM, Cao RX, Yang BS. PEGylated nanodiamond for chemotherapeutic drug delivery. Diam Relat Mater. 2013;36:26-34.
10. Schrand AM, Dai L, Schlager JJ, Hussain SM, Osawa E. Differential biocompatibility of carbon nanotubes and nanodiamonds. Diam Relat Mater. 2007;16:2118-2123.
11. Zhang XY, Hu WB, Li J, Tao L, Wei Y. A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond. Toxicol Res. 2012;1:62-68.
12. Puzyr AP, Baron AV, Purtov KV, et al. Nanodiamonds with novel properties: a biological study. Diam Relat Mater. 2007;16:2124-2128.
13. Yuan Y, Chen YW, Liu JH, Wang H, Liu Y. Biodistribution and fate of nanodiamonds in vivo. Diam Relat Mater. 2009;18:95-100.
14. Chang HC. In: Ho D, editor. Nanodiamonds. New York, NY, USA: Springer; 2010.
15. Fu CC, Lee HY, Chen K, et al. Characterization and application of single fuorescent nanodiamonds as cellular biomarkers. Proc Natl Acad Sci U S A. 2007;104:727-732.
16. Zhang BL, Li YQ, Fang CY, et al. Receptor-mediated cellular uptake of folate-conjugated fuorescent nanodiamonds: a combined ensemble and single-particle study. Small. 2009;5:2716-2721.
17. Li YQ, Zhou XP. Transferrin-coupled fluorescence nanodiamonds as targeting intracellular transporters: an investigation of the uptake mechanism. Diam Relat Mater. 2010;1:1163-1167.
18. Fu YJ, An N, Zheng SH, Liang AH, Li YQ. BmK CT-conjugated fuorescence nanodiamond as potential glioma-targeted imaging and drug. Diam Relat Mater. 2012;21:73-76.
19. Mohan N, Chen CS, Hsieh HH, Wu YC, Chang HC. In vivo imaging and toxicity assessments of fuorescent nanodiamonds in Caenorhabditis elegans. Nano Lett. 2010;10:3692-3699.
20. 18F radionuclide emission. ACS Nano. 2011;5:5552-5559.
21. Vaijayanthimala V, Cheng PY, Yeh SH, et al. The long-term stability and biocompatibility of fluorescent nanodiamond as an in vivo contrast agent. Biomaterials. 2012;33:7794-7802.
22. Service RF. Nanotechnology takes aim at cancer. Science. 2005;310: 1132-1134.
23. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751-760.
24. Sanhai WR, Sakamoto JH, Canady R, Ferrari M. Seven challenges for nanomedicine. Nat Nanotechnol. 2008;3:242-244.
25. Huang H, Pierstorff E, Osawa E, Ho D. Active nanodiamond hydrogels for chemotherapeutic delivery. Nano Lett. 2007;7:3305-3314.
26. Chow EK, Zhang XQ, Chen M, et al. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Sci Transl Med. 2011;3:73ra21.
27. Khaled G. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target. 2007;15:457-464.
28. Li JX, Liu JC, Wang K, Yang XG. Gadolinium-containing bioparticles as an active entity to promote cell cycle progression in mouse embryo fibroblast NIH3T3 cells. J Biol Inorg Chem. 2010;15:547-557.
29. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs1. Cancer Res. 1986;46: 6387-6392.
30. Li YQ, Zhou XP, Wang DX, Yang BS, Yang P. Nanodiamond mediated delivery of chemotherapeutic drugs. J Mater Chem. 2011;21: 16406-16412.
31. Muggia FM. Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention. Clin Cancer Res. 1999;5:7-8.
32. VonMaltzahn G, Park JH, Lin KY, et al. Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater. 2011;10:545-552.
33. Wang J, Tian S, Petros RA, Napier ME, DeSimone JM. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. J Am Chem Soc. 2010;132:11306-11313.
34. Lu J, Liong M, Li ZX, Zink JI, Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small. 2010;6:1794-1805.
35. Rejmanova P, Kopecek J, Pohl J, Baudys M, Kostka V. Polymers containing enzymatically degradable bonds 8. Degradation of oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B. Makromol Chem. 1983;184: 2009-2020.
36. Krueger A. New carbon materials: biological applications of functionalized nanodiamond materials. Chem Eur J. 2008;14:1382-1390.
37. Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small. 2010;6:12-21.
38. Chithrani BD, Chan WCW. Elucidating the mechanism of cellar uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007;7:1542-1550.
39. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6:662-668.
40. Schrand AM, Johnson J, Dai L, Hussain SM, Schlager JJ, Zhu L. Cytotoxicity and genotoxicity of carbon nanomaterials. In: Webster TJ, editor. Safety of Nanoparticles, Nanostructure Science and Technology. Morwell, Australia: Springer; 2009.
41. Xing Y, Xiong W, Zhu L, Osawa E, Hussin S, Dai L. DNA damage in embryonic stem cells caused by nanodiamonds. ACS Nano. 2011;5: 2376-2384.
42. Vaijayanthimala V, Tzeng YK, Chang HC, Li CL. The biocompatibility of fuorescent nanodiamonds and their mechanism of cellular uptake. Nanotechnology. 2009;20:425103.
43. Yuan Y, Wang X, Jia G, et al. Pulmonary toxicity and translocation of nanodiamonds in mice. Diam Relat Mater. 2010;19:291-299.
44. Liu T, Li L, Fu C, Liu H, Chen D, Tang F. Pathological mechanisms of liver injury caused by injection of silica nanoparticles. Biomaterials. 2012;33:2399-2407.
45. Nguyen TTB, Chang HC, Wu VWK. Adsorption and hydrolytic activity of lysozyme on diamond nanocrystallites. Diam Relat Mater. 2007;16:872-876.
46. Barnard AS. Self-assembly in nanodiamond agglutinates. J Mater Chem. 2008;18:4038-4041.